Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2 . Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs) , Disitamab vedotin ( Disitamab vedotin (HY-P9985) )In VivoDisitamab (27 mg/kg i.v. once 5 mL/kg)
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2 . Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs) , Disitamab vedotin ( Disitamab vedotin (HY-P9985) )In VivoDisitamab (27 mg/kg i.v. once 5 mL/kg)
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2 . Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs) , Disitamab vedotin ( Disitamab vedotin (HY-P9985) )In VivoDisitamab (27 mg/kg i.v. once 5 mL/kg)
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2 . Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs) , Disitamab vedotin ( Disitamab vedotin (HY-P9985) )In VivoDisitamab (27 mg/kg i.v. once 5 mL/kg)
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2 . Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs) , Disitamab vedotin ( Disitamab vedotin (HY-P9985) )In VivoDisitamab (27 mg/kg i.v. once 5 mL/kg)
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2 . Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs) , Disitamab vedotin ( Disitamab vedotin (HY-P9985) )In VivoDisitamab (27 mg/kg i.v. once 5 mL/kg)